Efficacy News and Research

RSS
Targeting ARF6 may be effectively prevent melanoma metastasis to lungs

Targeting ARF6 may be effectively prevent melanoma metastasis to lungs

New research findings could lead to development of effective therapies for anxiety disorders

New research findings could lead to development of effective therapies for anxiety disorders

Continuous dyskinesia monitoring technology for Parkinson’s to be developed by Great Lakes NeuroTechnologies

Continuous dyskinesia monitoring technology for Parkinson’s to be developed by Great Lakes NeuroTechnologies

FES cycling associated with improvements in individuals with chronic spinal cord injury

FES cycling associated with improvements in individuals with chronic spinal cord injury

Mirabegron reduces frequency of incontinence episodes in phase III trial

Mirabegron reduces frequency of incontinence episodes in phase III trial

Sanford-Burnham enters into partnership to test furin for treatment of dengue fever

Sanford-Burnham enters into partnership to test furin for treatment of dengue fever

Study finds antiretroviral-based strategies to prevent HIV infection among women prove ineffective

Study finds antiretroviral-based strategies to prevent HIV infection among women prove ineffective

HCV and HIV co-infected patients achieve early treatment success with faldaprevir, PegIFN/RBV

HCV and HIV co-infected patients achieve early treatment success with faldaprevir, PegIFN/RBV

Screening colonoscopy associated with reduced advanced colorectal cancer diagnoses

Screening colonoscopy associated with reduced advanced colorectal cancer diagnoses

FDA approves Tenaxis Medical’s ArterX Surgical Sealant

FDA approves Tenaxis Medical’s ArterX Surgical Sealant

Médecins Sans Frontières’ concerns over TPP negotiations

Médecins Sans Frontières’ concerns over TPP negotiations

PsiOxus completes enrollment in MT-102 Phase II trial on cancer cachexia

PsiOxus completes enrollment in MT-102 Phase II trial on cancer cachexia

DBV Technologies total revenues increase to €2,776,588 for full year 2012

DBV Technologies total revenues increase to €2,776,588 for full year 2012

Regeneron, Sanofi announce pooled data from Phase 1b trials with dupilumab for atopic dermatitis

Regeneron, Sanofi announce pooled data from Phase 1b trials with dupilumab for atopic dermatitis

Melanoma tumours deliberately create conditions that knock out body's premier immune defence

Melanoma tumours deliberately create conditions that knock out body's premier immune defence

New data from KYTHERA Biopharmaceuticals’ ATX-101 studies on double chin

New data from KYTHERA Biopharmaceuticals’ ATX-101 studies on double chin

Pivotal study of olesoxime in Spinal Muscular Atrophy receives positive interim review

Pivotal study of olesoxime in Spinal Muscular Atrophy receives positive interim review

Urea cycle disorder patient successfully treated by Promethera(R) HepaStem in Phase I/II trial in France

Urea cycle disorder patient successfully treated by Promethera(R) HepaStem in Phase I/II trial in France

Scientists take important step toward designing a uniform protocol for microbiome research

Scientists take important step toward designing a uniform protocol for microbiome research

Oraya Therapy safe and effective for patients with wet AMD

Oraya Therapy safe and effective for patients with wet AMD

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.